Article Versions Notes

Baliou S, Pelagiadis I, Apetroaei M-M, Vakonaki E, Arsene AL, Hatzidaki E, Tzatzarakis MN, Ioannou P, Tsatsakis A, Stiakaki E. The Telomere Length Signature in Leukemias—From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase. Cancers. 2025; 17(12):1936. https://doi.org/10.3390/cancers17121936

Baliou, Stella, Iordanis Pelagiadis, Miruna-Maria Apetroaei, Elena Vakonaki, Andreea Letiția Arsene, Eleftheria Hatzidaki, Manolis N. Tzatzarakis, Petros Ioannou, Aristides Tsatsakis, and Eftichia Stiakaki. 2025. "The Telomere Length Signature in Leukemias—From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase" Cancers 17, no. 12: 1936. https://doi.org/10.3390/cancers17121936

Baliou, S., Pelagiadis, I., Apetroaei, M.-M., Vakonaki, E., Arsene, A. L., Hatzidaki, E., Tzatzarakis, M. N., Ioannou, P., Tsatsakis, A., & Stiakaki, E. (2025). The Telomere Length Signature in Leukemias—From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase. Cancers, 17(12), 1936. https://doi.org/10.3390/cancers17121936